Not recruiting
Prostate cancer metastatic
Not recruitingStudy on LAVA-1207 and Pembrolizumab for Patients with Advanced Prostate Cancer Resistant to Treatment
Registered drugNo placebo
Study on LAVA-1207 and Pembrolizumab for Patients with Advanced Prostate Cancer Resistant to Treatment
Registered drugNo placebo
- Disease:Prostate cancer metastatic
- Substances:PembrolizumabHumanised Bispecific Immunoglobulin Vhh Fragments Against Psma And Vgamma9Vdelta2 T-Cell Receptor
Countries:
The Netherlands
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Pembrolizumab

